Author: Michelle Liu
ACCESS CHINA is the most effective deal-making platform for Western pharma and biotech leaders looking to enter or expand in the Chinese market. ACCESS CHINA creates invaluable BD opportunities by directly connecting and meeting with the right partners for development, licensing or commercial collaborations.
Who are the attendees ?
50% are Chinese pharma/biotechs looking for in-licensing opportunities to enrich pipeline
25% are Pharma/biotechs outside China looking for in-licensing opportunities to enrich pipeline in China and other regions
15% are VCs and PEs looking for pharma/biotech investment opportunities in China